GINO BIOW Stock Nasdaq
Equities
DNA
US37611X1000
Biotechnology & Medical Research
Sales 2024 * | 199M 272M | Sales 2025 * | 265M 362M | Capitalization | 1.86B 2.54B |
---|---|---|---|---|---|
Net income 2024 * | -569M -778M | Net income 2025 * | -479M -655M | EV / Sales 2024 * | 6.25 x |
Net cash position 2024 * | 613M 838M | Net cash position 2025 * | 557M 761M | EV / Sales 2025 * | 4.92 x |
P/E ratio 2024 * |
-2.97
x | P/E ratio 2025 * |
-3.45
x | Employees | 1,218 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.77% |
Latest transcript on GINO BIOW
Managers | Title | Age | Since |
---|---|---|---|
Austin Che
FOU | Founder | - | 07-12-31 |
Founder | - | 07-12-31 | |
Reshma Shetty
FOU | Founder | 43 | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 21-09-15 |
Arie Belldegrun
BRD | Director/Board Member | 74 | 20-12-31 |
Marijn Dekkers
CHM | Chairman | 65 | 21-09-15 |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+43.96% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |